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Signal-generationElectron paramagnetic resonance imaging (EPRI) allows detection and localization of paramagnetic spin
probes in vivo and in real time. We have shown that nitroxide spin probes entrapped in the intracellular
milieu can be imaged by EPRI. Therefore, with the development of a tumor-targetable vehicle that can
efﬁciently deliver nitroxides into cells, it should be possible to use nitroxide spin probes to label and image
cells in a tumor. In this study, we assess the potential of liposomes as a delivery vehicle for imaging probes.
We demonstrate that liposomes can stably encapsulate nitroxides at very high concentrations (N100 mM), at
which nitroxides exhibit concentration-dependent quenching of their EPR signal—a process analogous to the
quenching of ﬂuorescent molecules. The encapsulating liposomes thus appear spectroscopically “dark”.
When the liposomes are endocytosed and degraded by cells, the encapsulated nitroxides are liberated and
diluted into the much larger intracellular volume. The consequent relief of quenching generates a robust
intracellular nitroxide signal that can be imaged. We show that through endocytosis of nitroxide-loaded
liposomes, CV1 cells can achieve intracellular nitroxide concentrations of ∼1 mM. By using tissue phantom
models, we verify that this concentration is more than sufﬁcient for in vivo EPR imaging.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The ability to image a population of cells on the basis of their
unique physiology is of clinical importance. For example, tumor
imaging enables detection of both primary lesions and secondary sites
of metastasis. Low-frequency electron paramagnetic resonance
imaging (EPRI) may be an ideal choice for an imaging modality, in
light of recent developments that allow non-invasive detection and
localization of paramagnetic free radical species in vivo [1,2].
Endogenous free radicals, being short-lived and of very low
abundance, cannot be detected in vivo by EPRI. In order to visualize
a tissue by EPRI, it is necessary to develop stable free radicals
(paramagnetic spin probes) that can target and label tumor tissue. The
power of EPRI, particularly using nitroxide probes, stems from the
ability to provide read-out on multiple functional aspects of tumor
tissue, including tissue oxygen tension [1,3], microviscosity—a
measure of how easily small molecules can diffuse locally [4], pH
[5], thiol concentration [6], and redox status [7].
We have demonstrated that anionic nitroxide radicals can be
loaded intracellularly to millimolar levels [8] and that nitroxides at
submillimolar concentrations are imaged with high signal-to-noisenter, University of Maryland
MD 21201, USA.
ll rights reserved.ratio by EPRI [4,9]. Although simple anionic nitroxides can be readily
loaded into cells, efﬁcient extrusion from cells by organic anion
transporters reduces their intracellular retention time at 37 °C [10].
Through rational structural designs that evade extrusion by cellular
anion transporters [10], we have extended the intracellular retention
times of anionic nitroxides to make EPR imaging studies feasible. For
example, (2,2,5,5-tetramethylpyrrolidin-1-oxyl-3-ylmethyl)amine-N,
N-diacetic acid (nitroxide 1; Fig. 1) has an intracellular exponential
lifetime (t1/e or τ) of just under 2 h at 37 °C—sufﬁciently long to
permit EPR imaging.
In earlier studies, we loaded carboxyl-bearing nitroxides into
cells through incubation with the corresponding acetoxymethyl
(AM) ester, which are labile to hydrolysis by intracellular esterases
[8]. During incubation, the AM esters, being nonionic and lipophilic,
enter cells by diffusing across the cell membrane. Once inside,
cellular esterases rapidly cleave the AM esters to unmask the
carboxylates that, being anionic, are retained inside cells. Although
the AM ester loading method works very well with cells in vitro,
the method is unsuitable for targeted delivery of imaging probes in
vivo for two reasons. First, small exogenous molecules like AM
esters are rapidly cleared from the circulation [11], which
minimizes tissue exposure and thus cellular loading. Second,
because intracellular esterases are ubiquitous and AM esters can
permeate into all cells, the AM ester loading method cannot target
a speciﬁc tissue or cell type.
Fig. 1. Nitroxides used in the present study.
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enhance selective uptake of chemotherapeutics into tumor cells
and minimize uptake by healthy tissue [12–14]. We wish to
investigate whether liposomes are also capable of delivering
sufﬁcient concentrations of nitroxides to cells for EPR imaging.
Liposomes are an attractive vehicle for delivering EPR imaging
probes to cells, as both nitroxides and ﬂuorophores can be
sequestered at high (mM) concentrations in the aqueous lumen of
the liposome [15,16]. Liposomally encapsulated nitroxides have
been used previously to assess the stability of liposomes as drug
carriers [17,18] and as a component in a system for in vitro cellular
oxygen measurements [19]. Liposomally encapsulated ﬂuorophores
have been widely used to investigate phenomena such as the pH
along endosomal pathways [16,20,21]. CV1 cells derived from
African green monkey kidney epithelium preferentially internalize
liposomes that bear negatively charged lipid head groups through
clathrin-dependent endocytosis [22,23]; subsequent disruption of
the liposomes in the endocytic pathway releases the contents of the
liposomes into the intracellular milieu [22]. As a model for studying
the feasibility of using liposomes for cellular delivery of EPR
imaging probes, CV1 cells are ideal because they preferentially
endocytose liposomes bearing negative surface charge 20 times
faster than neutral liposomes [24].
For in vivo applications, imaging probes inside unendocytosed
liposomes in circulation could contribute undesirable background
signal. Encapsulating nitroxides in liposomes presents a mechanism
to circumvent this problem. It is possible to minimize this
background by exploiting self-quenching—a concentration-depen-
dent loss of spectroscopic signal that occurs in both nitroxides and
ﬂuorophores. When encapsulated at high concentrations inside
liposomes, the imaging probes self-quench and are thus spectro-
scopically “dark” and invisible by EPRI. After cellular uptake,
disruption of the liposomes releases the probes into the cellular
volume. The consequent dequenching of the imaging probes would
make the cells “bright” and visible by EPRI. Liposomal endocytosis
and dequenching of imaging probes creates a cell-activated signal-
generating mechanism.
In the present study, we show that imaging probes such as
nitroxide 1 and 6-carboxyﬂuorescein can be stably encapsulated in
liposomes at sufﬁciently high concentrations to maximize self-
quenching. Upon cell-speciﬁc endocytosis, release of imaging probes
into the intracellular environment relieves self-quenching to generate
robust intracellular spectral signals. Furthermore, we show that
through liposomal delivery, nitroxide 1 can accumulate intracellularly
to concentrations that are sufﬁcient to enable EPR imaging at high
signal-to-noise ratio (SNR).
2. Materials and methods
2.1. General materials and methods
(2,2,5,5-Tetramethylpyrrolidin-1-oxyl-3-ylmethyl)amine-N,N-
diacetate dipotassium salt (nitroxide 1) was synthesized as
previously described [10]. 6-Carboxyﬂuorescein (CF) and 3-car-
boxy-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl (nitroxide 2) were fromSigma (St. Louis, MO). The potassium salts of CF and nitroxide 2
were generated by adding appropriate equivalents of KOH. For CF,
0.3 ml of 1 M KOH was added to 0.0376 g CF, and the sample was
made to a ﬁnal concentration of 100 mM with deionized water. For
nitroxide 2, 0.15 ml of 1 M KOH was added to 0.0279 g of nitroxide,
and the mixture was made to a ﬁnal concentration of 150 mM. Cell
culture media and biochemicals were from Invitrogen (Carlsbad,
CA). Fetal bovine serum (FBS) was from Atlanta Biologicals
(Lawrenceville, GA). All animal protocols were approved by the
Institutional Animal Care and Use Committee at the University of
Chicago. Data analyses and presentation were performed with
Origin 8.0 (OriginLabs, Northampton, MA), Matlab 2007a (The
MathWorks, Natick, MA), and Adobe Photoshop CS3 (Adobe Corp.,
San Jose, CA).
2.2. Statistical analysis
One-way ANOVA analysis was used to determine differences
among data sets containing more than two groups. A 95% conﬁdence
interval (pb0.05) was used to determine signiﬁcance, and post hoc
analysis was performed according to the Scheffe method of means
comparison. All values presented are mean values±standard
deviation.
2.3. Liposome preparation
Liposomes were composed of 1,2-distearoylphosphatidylcholine
(DSPC), cholesterol (Chol), L-α-phosphatidylserine (PS; porcine brain
isolate), and 1,2-dipalmitoyl-phosphatidylethanolamine-N-(lissa-
mine rhodamine B sulfonyl) ammonium salt (Rhod-PE) in the molar
ratio 3:2:0.3:0.003 (DSPC:Chol:PS:Rhod-PE). All lipids were obtained
from Avanti Polar Lipids (Alabaster, AL). Where noted, liposomes
were made without the addition of PS or Rhod-PE. A solution of
10 μmol phospholipid in 100 μl EtOH was injected into 1 ml of rapidly
stirred aqueous solution of 100 mM CF or 150 mM nitroxide 1 (pH
8.0–8.5). The mixture was extruded 11 times through a 100-nm
porosity ﬁlter membrane in a Mini Extruder (Avanti Polar Lipids) to
yield a suspension of liposomes. All solutions and the extruder were
maintained at N55 °C to ensure ﬂuidity of the lipid phase. Liposomes
were puriﬁed with Sephadex G-50 resin (∼4 g; GE Healthcare,
Piscataway, NJ), which was hydrated with H2O, packed into a
FlexColumn (15×300 mm; Kimbal-Kontes, Vineland, NJ), and
equilibrated with Dulbecco's phosphate-buffered saline (DPBS)
containing Ca2+ and Mg2+. Gel ﬁltration yielded ∼4 ml of puriﬁed
liposome suspension in DPBS (ﬁnal phospholipid concentration
∼2 μmol/ml), which was stored at 4 °C until use. Phospholipid
concentration was determined using the phosphate analysis protocol
of Bartlett [25].
2.4. Liposomal encapsulation measurements
Liposomes encapsulating quenched CF or nitroxide 1 were
measured for ﬂuorescence or EPR spectroscopic signal, respectively.
Identical spectral measurements were made before and after lysis.
Lysis was achieved by the addition of 240 μM digitonin, heating to
95 °C for 30 s, and sonication for 1 min. To assess long-term
stability of liposomes encapsulating CF or nitroxide 1, a reference
ﬂuorescence or EPR spectrum was acquired immediately after
preparation; the liposomes were then incubated at 37 °C in 90%
DPBS–10% FBS or in 5% DPBS–95% FBS (all percentages by volume).
Aliquots were taken at various times thereafter for spectroscopy.
Any leaked probe would be dequenched and thus increase the
spectroscopic signal above the initial reference baseline value. At
each time point, the percentage difference between the “leak signal”
and total signal (measured after lysis) represents the fraction of
probe still encapsulated in liposomes.
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CV1 cells (ATCC, Manassas, VA) were maintained at 37 °C in
Dulbecco's modiﬁed Eagle medium (DMEM) supplemented with 10%
(v/v) FBS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml
streptomycin, under a 5% CO2 atmosphere.
2.6. Cellular uptake of liposomes loaded with CF
CV1 cells (∼8×104) were plated on 25-mm round no. 1 glass
coverslips for 24–48 h. Liposomes encapsulating 100 mM CF were
prepared with or without PS and diluted to a concentration of
0.05 μmol of phospholipid in 2 ml Hanks' balanced salt solution
(HBSS). Cells were incubated with liposome suspensions at 37 °C for
2 h and then washed thrice with Ca2+- and Mg2+-free HBSS
containing 1 mM ethylenediaminetetraacetic acid (EDTA). Thereafter,
the cells were maintained in normal (Ca2+- and Mg2+-containing)
HBSS for ﬂuorescence microscopy.
2.7. Cellular uptake of liposomes loaded with nitroxide
Replicate 60-mm plastic Petri dishes of CV1 cells were incubated
at 37 °C with a suspension of liposomes encapsulating 150 mM
nitroxide 1. Liposomes were at a concentration of 0.1 μmol of
phospholipid in 4 ml HBSS. At each time point, cells were washed
with HBSS and then released from the plate with trypsin–EDTA
solution. Cells were centrifuged at 145×g for 3 min, and the pellet
was washed twice with Ca2+- and Mg2+-free HBSS containing
1 mM EDTA. After the ﬁnal wash, the pellet was resuspended in
400 μl normal HBSS. Cells were lysed with 120 μM digitonin and
sonicated for 1 min. Nitroxide and Rhod-PE in the lysates were
analyzed by EPR and ﬂuorescence spectroscopy, respectively. The
nitroxide concentration in each 400-μl sample was determined
using a calibration curve of spectral intensity versus nitroxide
concentration. Control dishes of cells were trypsinized, washed, and
counted to determine the average number of cells in each dish
(6.25×105 cells); total intracellular volume was estimated using a
previously estimated intracellular volume of 1.3×10−12 L/cell [26].
The average intracellular nitroxide concentration was then estimat-
ed through volumetric calculations.
2.8. Implantation of agarose cylinder phantom in an anesthetized mouse
A 4% (w/v) agarose solution in PBS was heated to boiling in a
microwave oven (∼60 s). Nitroxide 2 was rapidly mixed into the hot
agarose to a ﬁnal concentration of 400 μM. The solution was
immediately drawn into a plastic serological pipette with a diameter
of 6 mm and allowed to cool to room temperature. The agarose gel
was removed from the pipette and cut into 10.2-mm-long cylinders. A
cylinder was sealed with a thin coat of Vetbond (3M Corporation, St.
Paul, MN) and surgically implanted in the leg of a C3H/HeN:Hsd
mouse anesthetized with 3.5% isoﬂurane inhalant in air. Immediately
prior to imaging, the mouse was euthanized with 5% isoﬂurane for
10 min.
2.9. EPR spectroscopy
A quartz ﬂat-cell cuvette was used for acquisition of EPR spectra in
an X-band spectrometer (E-109; Varian Associates, Palo Alto, CA) at
the following settings: microwave power, 20 mW; frequency, 9.55
GHz; ﬁeld center, 333.5 mT; modulation amplitude, 0.05 mT;
modulation frequency, 100 kHz; and time constant, 0.5 s. A ﬁeld
range of 8 mT was scanned in 180 s. EWWIN software (Scientiﬁc
Software Services, Plymouth, MI) was used for data acquisition.
Reported spectral intensity represents the peak-to-peak amplitude of
the center line in the three-line nitroxide spectrum.2.10. Fluorescence spectroscopy
Fluorescence spectra were recorded on a dual-excitation spectro-
ﬂuorometer (model CM1T-10I; SPEX Industries, Metuchen, NJ). Instru-
ment control and data acquisition were performed with Datamax
software (Galactic Industries Corporation, Salem, NH). Emission and
excitation spectra were acquired to determine optimal wavelength
settings (6-carboxyﬂuorescein: λex=490 nm, λem=515 nm; Rhod-PE:
λex=550 nm, λem=588 nm).
2.11. Fluorescence microscopy
Fluorescence imageswere acquired on an inverted epiﬂuorescence
microscope (Eclipse TE200; Nikon Corp., Tokyo, Japan) equipped with
a 40× oil-immersion objective (Super Fluor, NA 1.4; Nikon). Excitation
light was delivered by a xenon source coupled to a monochromator
(PolyChrome II; TILL Photonics, Gräfelﬁng, Germany). Fluorescence
was passed through an appropriate band-pass ﬁlter before capture by
a CCD camera (CoolSnap HQ; Roper Scientiﬁc, Tucson, AZ). MetaFluor
software (Molecular Devices, Downingtown, PA) was used for
instrument control and image acquisition.
2.12. EPR imaging and data reconstruction
A euthanized mouse with an implanted agarose cylinder impreg-
nated with nitroxide 2 was positioned in the approximate center of
the resonant cavity of a 250-MHz EPR imaging spectrometer [27]
ﬁtted with a loop-gap resonator with a single loop and a single gap.
The sample-holding loop was 25 mm in diameter and 15 mm deep
with a loaded Q of 92. A 0.41-mT spectral window encompassed the
central spectral peak of the nitroxide. Other instrumental parameters
were as follows: RF power, 6 dB; modulation amplitude and
frequency, 0.198 mT and 5.120 kHz, respectively; lock-in time
constant, 30 ms, with a 30-ms per point dwell time; 256 points per
projection; ﬁeld gradient, 98.1 mT/m.
Continuous wave (CW) EPR intensity images were obtained using
an essentially tomographic technique. Projections are deﬁned as ﬁeld-
swept CW spectra in the presence of a 98.1-mT/m gradient and were
obtained in ∼8 s, with 256 points uniformly spaced in the magnetic
ﬁeld. A total of 66 projections were sampled at 10 polar direction
angles with multiple azimuthal angles sampled at each polar
coordinate. The number of azimuthal projections acquired was
dependent on the value of each polar coordinate. As radial distances
between azimuthal angles become smaller at higher polar angles,
maintaining even spacing between projections required fewer
azimuthal angles to be sampled. A ﬁltered back-projection algorithm
was used for image reconstruction [28]. Projections were ﬁltered
using a simple cutoff of the image response frequency to half the
Nyquist sampling limit. Images were reconstructed without correc-
tion for the effect of the two other spectral lines not included in the
spectral window of 0.41 mT. Since the manifold splittings were
greater than 1.4 mT, there was no artifact or sacriﬁce in resolution.
Spatial resolution of an imaging system is commonly deﬁned by
the full-width at half-maximum (FWHM) of a point spread function
(PSF). For a phantom cylinder of known dimensions, the FWHM can
be estimated from the edge proﬁle of signal intensity [29]. Brieﬂy, in a
two-dimensional slice containing the end view of the cylinder, 20
intensity proﬁles uniformly spaced around the circumference of the
cylinder were sampled. This was repeated for each of ﬁve two-
dimensional slices spaced uniformly along the long axis of the
cylinder. The average FWHM determined from the 100 edge proﬁle
measurements was 2.6±0.2 mm. The SNR for the phantom cylinder
was determined by selecting a region of the image displaying signal
and evaluating the mean intensity of the pixels from this region. A
region with the same number of pixels outside the signal area was
selected, and the standard deviation (SD) of the pixel intensity was
Fig. 3. Intact liposomes encapsulating high probe concentrations are spectroscopically
“dark”. (A) Spectroscopic signal intensity of suspensions of liposomes containing
100 mM CF or 150 mM nitroxide 1 before and after lysis (n=3; for visual clarity, error
bars are omitted on the two “Intact” measurements, but both were b12% of the mean
value). (B) EPR spectra of liposomes encapsulating 150 mM nitroxide 1. Intact
liposomes (black trace) contain quenched nitroxide and show only a feeble EPR signal.
Lysis releases nitroxides into bulk solution to produce a robust dequenched signal (red
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signal region to the SD outside the region, was 39.
3. Results
3.1. Nitroxides and 6-carboxyﬂuorescein exhibit
concentration-dependent self-quenching
To document concentration-dependent self-quenching, we
recorded the EPR spectra of nitroxide 2 and the ﬂuorescence emission
spectra of CF at various concentrations. In Fig. 2, the molar
spectroscopic signals of CF and nitroxides are plotted against
concentration. For CF, self-quenching becomes detectable at ∼50 μM
and reaches a maximum at concentrations ∼1 mM. With nitroxide 2,
self-quenching is measurable at ∼1 mM and reaches a maximum at
∼30 mM. Increasing the luminal concentration in the liposome above
these levels does not further increase quenching but does enable
delivery of greater amounts of the imaging probes per liposome.
3.2. Liposomes encapsulating high concentrations of probe are
spectroscopically “dark”
Liposomes encapsulating either 100 mM CF or 150 mM nitroxide 1
were prepared. Immediately after preparation, liposomes were
analyzed by the appropriate spectroscopic method before and after
lysis. Lysis of CF-containing liposomes resulted in a 34-fold increase in
ﬂuorescence intensity, while lysis of nitroxide-containing liposomes
yielded a 90-fold increase in EPR signal intensity (n=3; Fig. 3A). For
the suspension of nitroxide-containing liposomes, the EPR spectra
acquired before and after lysis are shown in Fig. 3B (black and red
traces, respectively). These spectra conﬁrm that nitroxides at high
concentration inside intact liposomes show only a feeble spectro-
scopic signal, but when released from lysed liposomes and diluted
into bulk solution, the nitroxides give a robust spectral signal. This
means that intact liposomes containing high concentrations of
nitroxide show minimal EPR spectral signal and are thus spectro-
scopically “dark”. Furthermore, this implies that the release and
dequenching of nitroxides following disruption of endocytosed
liposomes could be an effective means for generating intracellular
spectral signal to make the cells appear “bright” in EPR imaging.
3.3. Liposomes encapsulating CF or nitroxides are stable
The suitability of liposomes as nitroxide delivery vehicles depends
on their stability. To assess long-term stability of liposomestrace).
Fig. 2. Concentration-dependent quenching of 6-carboxyﬂuorescein and nitroxide 2.encapsulating CF or nitroxide 1, a reference ﬂuorescence or EPR
spectrum was acquired immediately after preparation; the liposomes
were then incubated at 37 °C in one of two solutions: (1) 90% DPBS–
10% FBS or (2) 5% DPBS–95% FBS. Aliquots were taken at various times
thereafter for spectroscopy. Any leaked probe would be dequenched
and thus increase the spectroscopic signal above the initial reference
value. At each time point, the percentage difference between the “leak
signal” and total signal (measured after lysis) represents the fraction
of probe still retained in liposomes. Fig. 4 shows fractional probe
retention as a function of time for both CF- and nitroxide-containing
liposomes. In 90% DPBS–10% FBS, CF-containing liposomes are
exceptionally stable. The retention time course is well ﬁt by a line
with a slope of −2.0×10−4%/h (n=3). Thus, there is negligible
leakage of CF even after 24 h. For liposomes encapsulating nitroxide 1,
in 90% DPBS–10% FBS, the retention time course follows a ﬁrst-order
exponential decay to a limiting retention of 85.2%, with a lifetime of
τ=8.7 h (n=3). Even in 5% DPBS–95% FBS, CF-containing liposomes
remain quite stable. The retention time course is well ﬁt by a line with
Fig. 4. Liposomes containing quenched CF or nitroxide 1 are stable. At various times
after preparation of liposomes, the amount of CF or nitroxide 1 remaining encapsulated
was assayed. In 90% DPBS–10% FBS, the data for CF-containing liposomes (ﬁlled circles)
are well ﬁt by a line with a slope of−2.0×10−4%/h (dashed line), whereas the data for
nitroxide-containing liposomes (ﬁlled triangles) are well ﬁt by a ﬁrst-order exponential
decay to a baseline of 85.2% with a time constant of τ=8.7 h (solid curve). In 5% DPBS–
95% FBS, the data for CF-containing liposomes (open circles) are well ﬁt by a line with a
slope of −0.12±0.011%/h (dashed line), whereas the data for nitroxide-containing
liposomes (open triangles) arewell ﬁt by a ﬁrst-order exponential decay to a baseline of
82.1% with a time constant of τ=0.81±0.068 h (solid curve). Each data point is the
mean of three samples. Where not shown, the error bar is smaller than the symbol.
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24 h. In 90% DPBS–10% FBS, liposomes encapsulating nitroxide 1 are
somewhat less stable: The retention time course follows a ﬁrst-order
exponential decay to a limiting retention of 82.1%, with a lifetime ofFig. 5. Fluorescence images of CV1 cells incubated with Rhod-PE-containing liposomes
encapsulating CF. Panels A, D, and G are bright-ﬁeld images; panels B, E, and H are
images acquired in the CF ﬂuorescence channel; panels C, F, and I are images acquired in
the Rhod-PE channel. Scale bar in panel A represents 20 μm. Cells avidly endocytosed
PS-bearing (negatively charged) liposomes at 37 °C, leading to bright intracellular CF
and Rhod-PE signals (A–C). In contrast, neutral liposomes (bearing no PS) are poorly
endocytosed at 37 °C (D–F). Endocytosis of negatively charged liposomes is blocked at
4 °C, resulting in no observable uptake of CF or Rhod-PE (G–I).τ=0.81±0.068 h (n=3). These results indicate that during the 7 h
in which cells are incubated with liposomes, the retention of
encapsulated nitroxide is N91% in 90% DPBS–10% FBS (and would be
N82% in 5% DPBS–95% FBS). Therefore, as vehicles for nitroxide
delivery, liposomes can be considered stable. For all subsequent
experiments, cells were incubated with liposomes in aqueous media
containing 10% FBS.
3.4. Dequenching of liposome-encapsulated CF generates intense
intracellular ﬂuorescence
Liposomes incorporating Rhod-PE, encapsulating 100 mM CF, and
having either negative or no surface charge (i.e., with or without PS)
were incubated with CV1 cells for 2 h. After incubation, the cells
received three brief washes with Ca2+- andMg2+-free PBS containing
2 mM ethylenediaminetetraacetic acid (EDTA) to remove unendocy-
tosed liposomes. CF and Rhod-PE associated with the cells wereFig. 6. Cellular uptake of Rhod-PE-containing liposomes encapsulating nitroxide 1.
Dishes of CV1 cells were incubated at 37 °C with liposomes containing PS and Rhod-PE
and loaded with nitroxide 1. At various times, intracellular nitroxide (A) and Rhod-PE
(B) were assayed spectroscopically. After 4 h, intracellular nitroxide concentration
increased to ∼1 mM through liposomal endocytosis, as veriﬁed by a parallel uptake of
liposomal Rhod-PE. Beyond 4 h, endocytosis slowed (as evidenced by the lack of further
Rhod-PE accumulation), and there was a decline of intracellular nitroxide signal. In
panel A, only down error bars are shown. Statistical signiﬁcance (pb0.05) is denoted by
asterisks and daggers. ANOVA values: panel A, F4,18=6.99; panel B, F4,14=66.15. Each
point is the average from assaying three to four dishes of cells.
2306 S.R. Burks et al. / Biochimica et Biophysica Acta 1788 (2009) 2301–2308visualized by ﬂuorescence microscopy (Fig. 5). When CV1 cells are
incubated with negatively charged (PS-bearing) liposomes at 37 °C
(Fig. 5A–C), intense, featureless green ﬂuorescence is observed
throughout the cells, indicating internalization and dequenching of
the liposome-encapsulated CF. Additionally, robust but structured red
ﬂuorescence of Rhod-PE is also visible inside the cells. This reﬂects
incorporation of the Rhod-PE lipids in the liposomes into cellular
membranes and therefore conﬁrms cellular uptake of the liposomes.
In contrast, when CV1 cells are incubated at 37 °C with neutral
liposomes (incorporating no PS), which are not rapidly endocytosed
by CV1 cells [30], only very feeble CF and rhodamine ﬂuorescence
could be detected inside cells (Fig. 5D–F). Finally, when CV1 cells are
incubated with negatively charged liposomes at 4 °C to block
endocytosis [22], no intracellular ﬂuorescence is visible (Fig. 5G–I).
These results indicate that endocytic uptake of liposomes can be
robust, and that relief of self-quenching of liposome-encapsulated
imaging probes is a means to generate bright intracellular signal.
3.5. Endocytosis of liposomes can achieve high intracellular
concentration of nitroxide
Replicate dishes of CV1 cells were incubated at 37 °C with
negatively charged (PS-containing) liposomes incorporating Rhod-
PE and encapsulating 150mMnitroxide 1. At various time points, cells
were brieﬂy washed thrice with Ca2+- and Mg2+-free PBS containing
2 mM EDTA to remove unendocytosed liposomes, and the amount of
nitroxide and Rhod-PE associated with the cells was determined
spectroscopically as described in Materials and methods. Cell-
associated nitroxide and Rhod-PE initially increased in parallel with
time of incubation (Fig. 6), as expected from endocytic uptake of
liposomes and their luminal contents. At 4 h after incubation, the
average intracellular nitroxide concentration was close to 1 mM. By
7 h, intracellular nitroxide concentration had declined to ∼300 μM,
while cell-associated Rhod-PE was unchanged from the level
observed at 4 h. This suggests that beyond 4 h, endocytosis becameFig. 7. EPR image of an agarose cylinder impregnated with 400 μMnitroxide 1 and implanted
in gray. (B–D) Cross-sectional views of the cylinder at the planes indicated in panel A. All axis
at right.very slow. As a result, without continual uptake of liposomes for
replenishment, there is a net loss of intracellular nitroxide signal.
Intracellular EPR signal can potentially decay by two mechanisms,
extrusion from the cell by organic anion transporters [10], and
intracellular reduction to the corresponding hydroxylamine [31,32],
which has no EPR signal. Even so, intracellular nitroxide concentra-
tions were in the several hundred micromolar range, which should be
visible by EPR imaging and permit cellular imaging studies [9].
3.6. Nitroxide-impregnated implants are visible by EPRI in vivo
We prepared agarose cylinders (4% w/w) impregnated with
400 μM nitroxide 2 and measuring 6 mm in diameter and 10.2 mm
in length. A cylinder was implanted subcutaneously in the leg of an
anesthetized mouse. The mouse was euthanized and immediately
placed in the cavity of a 250-MHz EPR spectrometer for imaging.
Euthanasia ensured that acquired images were free of motion
artifacts. As shown in Fig. 7, the agarose implant is clearly visible in
the EPR image. The known geometry of the cylinder is reproduced in
the image with a resolution of 2.6±0.2 mm. The nitroxide signal
emanating from the cylinder shows high contrast against the
surrounding background and was imaged with SNR=39. This
experiment shows that at 400 μM, nitroxides are easily detectable
and very well imaged in biological tissue by EPRI.
4. Discussion
In this study, we demonstrate that nitroxides, as well as
ﬂuorophores, can be encapsulated at self-quenching concentrations
in liposomes. Such liposomes exhibit only feeble spectral signals,
making them appear “dark” in the appropriate imaging modality.
Upon endocytosis of the liposomes by cells, the encapsulated imaging
probes are released into the much larger intracellular volume and
become dequenched. Therefore, cells that have endocytosed lipo-
somes appear “bright” in the appropriate imaging modality.in a mouse. (A) Surface intensity plot of the cylinder with cross-sectional planes shown
labels are in centimeters. Intensity is encoded according to the pseudocolor scale shown
2307S.R. Burks et al. / Biochimica et Biophysica Acta 1788 (2009) 2301–2308We showed that cells can avidly endocytose nitroxide-containing
liposomes to achieve intracellular nitroxide concentration close to
1mM (Fig. 6). Thus, liposomes have potential utility for delivering EPR
imaging probes to cells efﬁciently through endocytosis. Importantly, a
phantom, consisting of an agarose cylinder impregnated with 400 μM
nitroxide and implanted in a mouse, was readily imaged by EPRI at
high contrast and with high SNR.
While liposomes are able to deliver high concentrations of EPR
imaging probes into cells in vitro, at least two conditions must be met
before in vivo EPRI of a physiologically distinct tissue such as a tumor
becomes a reality. First, in order to image a tumor with high contrast,
the tumor cells must endocytose liposomes much more efﬁciently
than the surrounding healthy tissue. This can be accomplished by
making the liposomes “targetable”—that is, they must incorporate
biochemical features that cause preferential uptake by the tumor.
Second, targetable liposomes must evade physiological clearance
mechanisms and persist in the circulation to maximize their targeting
potential.
There are several liposomal targeting approaches that require
decorating the liposomal surface with markers that induce preferen-
tial uptake by tumors. These have been developedmainly for selective
delivery of anti-cancer drugs but could easily be adapted for delivery
of EPR imaging agents. One approach is the conjugation of peptides
such as penetrin (PEN) or the HIV transactivator of transcription
(TAT) peptide to the liposome. This approach is not intrinsically
selective for tumor cells but rather relies on the higher permeability of
tumor vasculature to increase extravasation of liposomes into the
interstitial space of tumors [33], where TAT or PEN facilitate liposome
translocation into tumor cells. Another mechanism that targets
tumors selectively is the immunoliposome—a liposomewhose surface
is decorated with antibody domains directed against internalizable
markers on the tumor cell. Immunoliposomes attach to tumor cells by
binding cell-surface antigens, which triggers endocytosis. Immunoli-
posomes have successfully targeted neuroblastomas and melanomas
overexpressing disialoganglioside GD2 [34,35], breast tumors over-
expressing the human epidermal growth factor receptor 2 (HER2)
[12,36]. Lastly, liposomes bearing ligands such as folate or transferrin
have been successfully used to target glioblastomas and the human
gastric cancer cell line MKN-45P that overexpress the appropriate
receptors [37–40].
Liposomes must evade physiological clearance mechanisms and
remain in circulation tomaximize uptake by the tumor. Liposomes are
ﬁltered from the circulation by the reticulo-endothelial system (RES)
of the liver and spleen [41]. Clearance by the RES can be retarded by
incorporating into the liposome a small proportion of lipid conjugated
to a hydrophilic polymer such as poly(ethyleneglycol) (PEG) to form
sterically stabilized liposomes [42]. The extent to which circulation
times are lengthened depends on themole fraction of PEG-conjugated
lipids in the liposome. Thus, the circulation times of liposomes can be
ﬁne-tuned to suit a speciﬁc application. Our preliminary studies have
shown that for liposomes encapsulating nitroxide 1, incorporating 5
mole-percent PEG-conjugated lipids lengthens the exponential
retention time from τ≈ 6 h to τ≈ 19 h (unpublished observations).
Finally, the EPR images presented here have excellent SNR and a
spatial resolution of 2.6 mm. Improvements in both of these
parameters can be brought about by rational design of nitroxide
imaging agents. For the nitroxides used in this study, hyperﬁne
interactions with the 14N nucleus (spin 1) split the electron resonance
into three spectral peaks that are each approximately one third the
total intensity. Because EPRI utilizes the amplitude of a single spectral
peak, the signal in the rest of the three-line spectrum is wasted.
Isotopic replacement with 15N (spin 1/2) results in the electron
resonance being split into two peaks, which brings a 50% increase in
SNR. Hyperﬁne interactions with protons broaden the EPR lines, with
consequent degradation in SNR and resolution. Hyperﬁne effects of
the deuteron are weaker owing to its smaller magnetic moment;therefore, deuteration of the nitroxide would sharpen EPR spectral
peaks and thus improve SNR and spatial resolution. These chemical
design improvements are being undertaken.
In summary, the present study suggests that it would be feasible to
use liposomes for targeted delivery of imaging agents to tumor cells
for in vivo EPR imaging.
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